Special light exposure is a salvation from oncology and injuries
Hudson Medical Research Institute and Swinburne University have developed a method for treating cancer and soft tissue injuries with light. According to Xinhua, a new photodynamic remedy IXV-PO2 has been tested on ovarian cancer cells. The remedy has allowed to destroy cancer cells in vitro.
Discovery: dietary supplements containing vitamin D can save you from death
Studies have shown that such supplements reduce the mortality rate caused by cancer, "Vademecum" reports. Scientists believe that it is critically important for cancer patients to maintain a normal level of vitamin D. Statistics shows that cancer patients often suffer from vitamin D deficiency. For residents of northern countries, this is especially important, because vitamin D is produced by the body due to sunlight. However, not everyone can boast about abundance of the liver, eggs and oily fish (sources of vitamin D) in the diet.
The first vaccine against "intestinal flu" is being prepared for testing.
Accordint to Xinhua, Chinese officials gave their permission for clinical trials of the world's first vaccine against norovirus (the most common cause of viral gastroenteritis). The vaccine developer is Shanghai Pasteur Institute of the Chinese Academy of Sciences. For four years the scientists have been worked on such vaccine.
Universal influenza vaccine may become real
Researchers from the University of Michigan and Ikana Medical School came close to creating a universal vaccine against influenza, Xinhua reports. The scientists have analyzed the condition of people infected with influenza and tested their blood for different antibodies.
Scientists promise to put an end to autoimmune disease
According to Eurek Alert, scientists of the University of Colorado have revealed an anti-inflammatory compound in Mycobacterium vaccae bacteria. This compound may help to cope with autoimmune diseases and mental disorders.
A unique anti-cancer drug will be tested.
Clinical trials of alofanib, Russian targeted antitumor drug, will be initiated shortly. These trials may show its safety and effectiveness, "Remedium" reports. They will be performed in patients with metastatic gastric cancer who do not respond to standard therapy.
ANANTA MEDICARE PARTICIPATED IN THE SCIENTIFIC-PRACTICAL SEMINAR "MULTIDISCIPLINARY APPROACH TO THE TREATMENT OF INTERNAL DISEASES"
On May 22, 2019, a scientific and practical seminar “Multidisciplinary approach to the treatment of internal diseases” was held in the teleconference format. The seminar took place in Kyiv, Chernigov, Cherkassy and Kropyvnytskiy. The seminar was attended by doctors of different specialties, such as therapists, family doctors, gastroenterologists, cardiologists, pediatricians and others.
Strokes and bacteria in the oral cavity are related, analysis showed
Scientists of the University of Tempere have shown that the brain emboli of patients with a stroke contain DNA of oral pathogens, reports Technology Networks. The researchers have analyzed the thrombus aspirates removed in 75 patients with stroke in emergency treatment. It turned out that 79% of aspirates contained DNA of bacteria that can be found on the teeth surface.
The most expensive medicine in the world has been launched on the market
A new remedy Zolgensma by Novartis Company is designed to replace long-term therapy for children with spinal muscular atrophy. The remedy is intended for a single use. Clinical trials that involved 36 children aged 2 weeks to 8 months have shown the effectiveness of such approach. The children demonstrated the acceleration of the development of motor skills (they better held their heads and sat). It should be reminded that spinal muscular atrophy often causes paralysis, breathing problems and death in the first months of a child’s life.
Neurologists advise to refuse popular remedies for gastrointestinal tract disorders
Elderly people taking proton pump inhibitors, which are usually prescribed for the treatment of acid-related diseases of the gastrointestinal tract, are at high risk of developing dementia. This is indicated by recent studies described in the Pharmaceutical Journal.